As Partners CO.,LTD. (TYO:160A)
Japan · Delayed Price · Currency is JPY 3,150.00
+40.00 (1.29%)
Sep 22, 2025, 3:30 PM JST
As Partners CO.,LTD. Revenue
In the fiscal year ending March 31, 2025, As Partners CO.,LTD. had annual revenue of 17.92B JPY with 4.47% growth. As Partners CO.,LTD. had revenue of 3.76B in the quarter ending March 31, 2025, a decrease of -13.22%.
Revenue
17.92B
Revenue Growth
+4.47%
P/S Ratio
0.63
Revenue / Employee
19.91M
Employees
900
Market Cap
11.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 17.92B | 767.28M | 4.47% |
| Mar 31, 2024 | 17.15B | 4.37B | 34.17% |
| Mar 31, 2023 | 12.78B | 1.87B | 17.14% |
| Mar 31, 2021 | 10.91B | 1.26B | 13.09% |
| Mar 31, 2020 | 9.65B | 1.12B | 13.17% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| HOYA Corporation | 876.09B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |